HUP0401633A2 - Irbesartan alkalmazása pulmonális magas vérnyomás megelőzésére vagy kezelésére alkalmas gyógyszerkészítmény előállítására - Google Patents

Irbesartan alkalmazása pulmonális magas vérnyomás megelőzésére vagy kezelésére alkalmas gyógyszerkészítmény előállítására

Info

Publication number
HUP0401633A2
HUP0401633A2 HU0401633A HUP0401633A HUP0401633A2 HU P0401633 A2 HUP0401633 A2 HU P0401633A2 HU 0401633 A HU0401633 A HU 0401633A HU P0401633 A HUP0401633 A HU P0401633A HU P0401633 A2 HUP0401633 A2 HU P0401633A2
Authority
HU
Hungary
Prior art keywords
preparation
irbesartan
prevent
pharmaceutical compositions
pulmonary hypertension
Prior art date
Application number
HU0401633A
Other languages
English (en)
Inventor
Sylvie Cosnier-Pucheu
Dino Nisato
Alain Roccon
Original Assignee
Sanofi-Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Synthelabo filed Critical Sanofi-Synthelabo
Publication of HUP0401633A2 publication Critical patent/HUP0401633A2/hu
Publication of HUP0401633A3 publication Critical patent/HUP0401633A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

A találmány irbesartan gyógyszerkészítmény előállítására valóalkalmazására vonatkozik, amely gyógyszerkészítmény pulmonálisartériás magas vérnyomás megelőzésére vagy kezelésére használható. Ó
HU0401633A 2001-10-26 2002-10-09 Use of irbesartan for the preparation of pharmaceutical compositions that are used to prevent or treat pulmonary hypertension HUP0401633A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0113936A FR2831446B1 (fr) 2001-10-26 2001-10-26 Utilisation de l'irbesartan pour la preparation de medicaments utiles pour la prevention ou le traitement de l'hypertension pulmonaire
PCT/FR2002/003439 WO2003035062A1 (fr) 2001-10-26 2002-10-09 Utilisation de l'irbesartan pour la preparation de medicaments utiles pour la prevention ou le traitement de l'hypertension pulmonaire

Publications (2)

Publication Number Publication Date
HUP0401633A2 true HUP0401633A2 (hu) 2004-12-28
HUP0401633A3 HUP0401633A3 (en) 2009-06-29

Family

ID=8868812

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0401633A HUP0401633A3 (en) 2001-10-26 2002-10-09 Use of irbesartan for the preparation of pharmaceutical compositions that are used to prevent or treat pulmonary hypertension

Country Status (24)

Country Link
US (2) US20040242567A1 (hu)
EP (1) EP1441723B1 (hu)
JP (1) JP4542777B2 (hu)
CN (1) CN100418526C (hu)
AT (1) ATE361071T1 (hu)
AU (1) AU2002350832B2 (hu)
BR (1) BR0213479A (hu)
CA (1) CA2461625C (hu)
CY (1) CY1106746T1 (hu)
DE (1) DE60219940T2 (hu)
DK (1) DK1441723T3 (hu)
EA (1) EA007952B1 (hu)
ES (1) ES2286304T3 (hu)
FR (1) FR2831446B1 (hu)
HU (1) HUP0401633A3 (hu)
IL (2) IL161116A0 (hu)
IS (1) IS2849B (hu)
MX (1) MXPA04003910A (hu)
NO (1) NO332313B1 (hu)
NZ (1) NZ532130A (hu)
PL (1) PL209263B1 (hu)
PT (1) PT1441723E (hu)
WO (1) WO2003035062A1 (hu)
ZA (1) ZA200402696B (hu)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8912174B2 (en) 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
US7811606B2 (en) 2003-04-16 2010-10-12 Dey, L.P. Nasal pharmaceutical formulations and methods of using the same
US9808471B2 (en) 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
US20040265238A1 (en) * 2003-06-27 2004-12-30 Imtiaz Chaudry Inhalable formulations for treating pulmonary hypertension and methods of using same
TR200301553A1 (tr) * 2003-09-18 2005-10-21 Nobel �La� Sanay�� Ve T�Caret A.�. İrbesartan etken maddesi içeren yeni oral farmasötik formülasyonlar
EP1750862B1 (en) 2004-06-04 2011-01-05 Teva Pharmaceutical Industries Ltd. Pharmaceutical composition containing irbesartan
WO2006067601A1 (en) * 2004-12-23 2006-06-29 Ranbaxy Laboratories Limited Oral pharmaceutical compositions of irbesartan and hydrochlorothiazide and processes for their preparation
CN100367959C (zh) * 2006-08-29 2008-02-13 陈俊云 一种含有依贝沙坦的药物
GB0617171D0 (en) * 2006-08-31 2006-10-11 Generics Uk Ltd Novel compositions and methods
US20240173302A1 (en) * 2021-03-23 2024-05-30 Dimerix Bioscience Pty Ltd Treatment of inflammatory diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5258510A (en) * 1989-10-20 1993-11-02 Otsuka Pharma Co Ltd Benzoheterocyclic compounds
NZ237476A (en) * 1990-03-20 1994-01-26 Sanofi Sa N-substituted heterocyclic compounds and pharmaceutical compositions.
US5270317A (en) * 1990-03-20 1993-12-14 Elf Sanofi N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present
RU2086544C1 (ru) * 1991-06-13 1997-08-10 Хоффманн-Ля Рош АГ Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина
US5292741A (en) * 1992-08-18 1994-03-08 Merck & Co., Inc. Macrocycles incorporating quinazolinones
US20020068740A1 (en) 1999-12-07 2002-06-06 Mylari Banavara L. Combination of aldose reductase inhibitors and antihypertensive agents for the treatment of diabetic complications

Also Published As

Publication number Publication date
IL161116A0 (en) 2004-08-31
IS2849B (is) 2013-09-15
PL368737A1 (en) 2005-04-04
IL161116A (en) 2010-12-30
EP1441723A1 (fr) 2004-08-04
JP4542777B2 (ja) 2010-09-15
DE60219940D1 (de) 2007-06-14
JP2005506369A (ja) 2005-03-03
IS7200A (is) 2004-03-29
ZA200402696B (en) 2005-06-29
US20040242567A1 (en) 2004-12-02
NO20041732L (no) 2004-07-23
US20090247510A1 (en) 2009-10-01
HUP0401633A3 (en) 2009-06-29
ES2286304T3 (es) 2007-12-01
DE60219940T2 (de) 2008-01-17
AU2002350832B2 (en) 2006-11-30
MXPA04003910A (es) 2004-07-23
EP1441723B1 (fr) 2007-05-02
WO2003035062A1 (fr) 2003-05-01
FR2831446A1 (fr) 2003-05-02
FR2831446B1 (fr) 2004-03-05
NZ532130A (en) 2006-10-27
BR0213479A (pt) 2004-11-03
ATE361071T1 (de) 2007-05-15
PL209263B1 (pl) 2011-08-31
NO332313B1 (no) 2012-08-27
PT1441723E (pt) 2007-07-26
EA007952B1 (ru) 2007-02-27
CN100418526C (zh) 2008-09-17
CA2461625A1 (en) 2003-05-01
CN1610548A (zh) 2005-04-27
CY1106746T1 (el) 2012-05-23
CA2461625C (en) 2011-07-05
US8088827B2 (en) 2012-01-03
DK1441723T3 (da) 2007-09-10
EA200400438A1 (ru) 2004-10-28

Similar Documents

Publication Publication Date Title
MY142329A (en) Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents.
ATE508735T1 (de) Pulmonale verabreichung von aminoglykosiden
HUP0303363A2 (hu) Kináz-inhibitor hatású heterociklusos vegyületek alkalmazása gyógyszerkészítmények előállítására
HK1092467A1 (en) N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses n-
IS7817A (is) Fenýlalanín afleiður sem dípeptidýl peptíðasa hindrar til að meðhöndla eða fyrirbyggja sykursýki.
SE0102315D0 (sv) Compounds
WO2004006858A3 (en) Compounds, compositions, and methods employing same
DK1556021T3 (da) Farmaceutiske sammensætninger omfattende flavonoider og menthol samt fremgangsmåder til behandling med brug af nævnte sammensætninger
NO20044658L (no) Anvendelse av osteoprotegerin til behandling og/eller forhindring av fibrotiske sykdommer
NO20055563L (no) Midler for behandlingen av lavere abdominale lidelser
WO2003088748A8 (en) Use of heme oxygenase-1 and products of heme degradation
WO2003106450A8 (de) Phenylaminopyrimidine und ihre verwendung als rho-kinase inhibitoren
NO20076405L (no) Anvendelse av 24-nor-UDCA
HUP0401633A2 (hu) Irbesartan alkalmazása pulmonális magas vérnyomás megelőzésére vagy kezelésére alkalmas gyógyszerkészítmény előállítására
ZA200502464B (en) Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome.
NO20054346L (no) Sammensetninger og fremgangsmater for forebygging og behandling av endotoksinrelaterte sykdommer og tilstander
NO20060420L (no) 2-aminobenzoylderivater
AU2002350832A1 (en) Use of irbesartan for the preparation of medicaments that are used to prevent or treat pulmonary hypertension
BR0111785A (pt) Composições e métodos para tratamento de candidìase
PL1651596T3 (pl) Nowe pochodne 4,4’ - ditiobis(3-aminobutano-1-sulfonianów) i zawierające je kompozycje
TW200603791A (en) Compounds and compositions as cathepsin S inhibitors
YU11904A (sh) Upotreba inhibitora il-18 kod poremećaja preosetljivosti
WO2004055001A3 (en) Rabeprazole calcium
EA200500865A1 (ru) Синергетическая комбинация, включающая рофлумиласт и r,r-формотерол
EE200400069A (et) Tsitalopraami kasutamine ravimkoostiste valmistamiseks kõrgenenud vererõhu raviks

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees